Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Julien Bollard, Verónica Miguela, Marina Ruiz De Galarreta, Anu Venkatesh, C. Billie Bian, Mark P. Roberto, Victoria Tovar, Daniela Sia, Pedro Molina-Sánchez, Christie B. Nguyen, Shigeki Nakagawa, Josep M. Llovet, Yujin Hoshida, Amaia Lujambio
Research output: Contribution to journal › Article › peer-review
204Scopus
citations
Fingerprint
Dive into the research topics of 'Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma'. Together they form a unique fingerprint.